A comprehensive review of small molecule drugs approved by the FDA in 2023: Advances and prospects

Bai, Yi-Ru; Seng, Dong-Jie; Xu, Ying; Zhang, Yao-Dong; Zhou, Wen-Juan; Jia, Yang-Yang; Song, Jian; He, Zhang-Xu; Liu, Hong-Min; Yuan, Shuo

doi:10.1016/j.ejmech.2024.116706

European Journal of Medicinal Chemistry

2024

DOI: 10.1016/j.ejmech.2024.116706

|View full text |Cite

A comprehensive review of small molecule drugs approved by the FDA in 2023: Advances and prospects

Yi-Ru Bai,

Dong-Jie Seng,

Ying Xu

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 127 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Simplified Gambogic Acid Prodrug Nanoparticles to Improve Efficiency and Reduce Toxicity for Clinical Translation Potential

Wang,

Xiao,

Zhang

et al. 2024

Adv Healthcare Materials

View full text Add to dashboard Cite

Poor in vivo characteristics of gambogic acid (GA) and difficulties in industrial manufacturing of its nanocarriers have hindered its clinical translation. Therefore, a reproducible nano‐drug delivery system must be developed to realize simpler manufacture and address inherent defects of GA, such as short circulation and severe side effects, in order to facilitate its clinical application. Herein, a drug self‐assembled nanoparticles (NPs) consisting of a hydrophobic prodrug based on GA and oleyl alcohol (OA), as well as vitamin E‐polyethylene glycol succinate (TPGS) as a shield to improve the stability of the NPs is reported. The preparation method is simple enough to stably facilitate large‐scale manufacturing. The self‐assembled NPs exhibit a remarkably high drug‐loading capacity, and their prolonged circulation enables the NPs to demonstrate superior antitumor efficacy in both cellular and animal models. The flexible hydrophobic long chain wraps GA groups, which mitigates vascular irritation and reduces hemolysis rates. Consequently, the prodrug nano‐system addresses GA‐related concerns regarding stability, efficacy, and safety, offering a simple, stable, and secure nano‐platform for similar candidate drugs.

show abstract

Simplified Gambogic Acid Prodrug Nanoparticles to Improve Efficiency and Reduce Toxicity for Clinical Translation Potential

Wang,

Xiao,

Zhang

et al. 2024

Adv Healthcare Materials

View full text Add to dashboard Cite

show abstract

Application of the Rumsfeld matrix to anticancer natural product target discovery

Bailly

2024

Pharmacological Research - Reports

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

A comprehensive review of small molecule drugs approved by the FDA in 2023: Advances and prospects

Cited by 2 publications

References 127 publications

Simplified Gambogic Acid Prodrug Nanoparticles to Improve Efficiency and Reduce Toxicity for Clinical Translation Potential

Simplified Gambogic Acid Prodrug Nanoparticles to Improve Efficiency and Reduce Toxicity for Clinical Translation Potential

Application of the Rumsfeld matrix to anticancer natural product target discovery

Contact Info

Product

Resources

About